Section of Urology, University of Chicago, Chicago, Illinois, USA.
J Urol. 2011 Jan;185(1):43-8. doi: 10.1016/j.juro.2010.09.019. Epub 2010 Nov 12.
We performed a multi-institutional retrospective cohort study to evaluate baseline renal function of patients who underwent partial nephrectomy for renal tumors, and determined rates of progression to higher stages of chronic kidney disease.
The Modification of Diet in Renal Disease study equation was used to estimate glomerular filtration rate. Preoperative and postoperative serum creatinine values were obtained from patients who underwent partial nephrectomy at 6 institutions with a normal contralateral kidney, and had baseline chronic kidney disease stage I (estimated glomerular filtration rate greater than 90 ml/minute/1.73 m(2)), II (estimated glomerular filtration rate 60 to 89 ml/minute/1.73 m(2)) or III (estimated glomerular filtration rate 30 to 59 ml/minute/1.73 m(2)). The end point was change in chronic kidney disease stage at long-term followup (3 to 18 months). Multivariate logistic and Cox regression models tested the association of newly acquired chronic kidney disease stage III or greater with pertinent demographic, tumor and surgical factors.
For 1,228 patients with followup creatinine data at least 3 months after partial nephrectomy median baseline glomerular filtration rate was 74 ml/minute/1.73 m(2). At baseline 19%, 59% and 22% of patients had chronic kidney disease stage I, II and III, respectively. At long-term followup for patients with baseline chronic kidney disease stage I or II median postoperative glomerular filtration rate was 67 ml/minute/1.73 m(2) with 29% having progression to chronic kidney disease stage III or greater. Increasing age, female gender, increasing tumor size, clamping of the renal artery and vein, and lower preoperative estimated glomerular filtration rate were independently associated with newly acquired chronic kidney disease stage III or greater. The presence of comorbid conditions such as coronary artery disease, diabetes mellitus or hypertension did not independently predict an increased risk of higher chronic kidney disease stage.
Chronic kidney disease stage III or greater will develop postoperatively in approximately a third of patients with an estimated glomerular filtration rate greater than 60 ml/minute/1.73 m(2), and this progression is associated with definable demographic, tumor and surgical factors.
我们进行了一项多机构回顾性队列研究,以评估接受肾部分切除术的肾肿瘤患者的基线肾功能,并确定进展为更高阶段慢性肾脏病的发生率。
使用肾脏病饮食改良研究方程估算肾小球滤过率。从 6 家机构接受肾部分切除术的患者中获得术前和术后血清肌酐值,这些患者的对侧肾脏正常,且基线慢性肾脏病分期为 I 期(估算肾小球滤过率大于 90ml/min/1.73m²)、II 期(估算肾小球滤过率 60 至 89ml/min/1.73m²)或 III 期(估算肾小球滤过率 30 至 59ml/min/1.73m²)。终点是长期随访(3 至 18 个月)时慢性肾脏病分期的变化。多变量逻辑和 Cox 回归模型测试了新获得的慢性肾脏病 III 期或更高级别与相关的人口统计学、肿瘤和手术因素的关联。
对于 1228 例至少在肾部分切除术后 3 个月有随访肌酐数据的患者,中位基线肾小球滤过率为 74ml/min/1.73m²。基线时,分别有 19%、59%和 22%的患者患有慢性肾脏病 I 期、II 期和 III 期。在基线慢性肾脏病 I 期或 II 期患者的长期随访中,中位术后肾小球滤过率为 67ml/min/1.73m²,有 29%的患者进展为慢性肾脏病 III 期或更高级别。年龄增长、女性、肿瘤增大、肾动静脉夹闭以及术前估算肾小球滤过率降低与新获得的慢性肾脏病 III 期或更高级别独立相关。合并症(如冠状动脉疾病、糖尿病或高血压)的存在并不能独立预测更高的慢性肾脏病分期的风险增加。
约三分之一估算肾小球滤过率大于 60ml/min/1.73m²的患者术后会出现慢性肾脏病 III 期或更高级别,这种进展与可定义的人口统计学、肿瘤和手术因素相关。